51991-821 : Everolimus 2.5 mg Oral Tablet


NDC51991-821
Labeler: Breckenridge Pharmaceutical, Inc.
Product Type: Human Prescription Drug
Drug Name:  Everolimus
Dosage Form: Oral Tablet
Application #: ANDA205426
Rev. Date: 


NDC Package Codes:

  • 51991-821-28: 4 BLISTER PACK IN 1 CARTON (51991‑821‑28) > 7 TABLET IN 1 BLISTER PACK (51991‑821‑99)
  • 51991-821-33: 30 TABLET IN 1 BOTTLE (51991‑821‑33)

Active Ingredients:

  • Everolimus

Dosage Strength:

  • 2.5 mg

Pharmaceutical Classes:

  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Decreased Immunologic Activity [PE]
  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]
  • mTOR Inhibitor Immunosuppressant [EPC]
  • mTOR Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 51991-379 Everolimus .25 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-380 Everolimus .5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-381 Everolimus .75 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-822 Everolimus 5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-823 Everolimus 7.5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-824 Everolimus 10 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 0054-0470 Everolimus .25 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0471 Everolimus .5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0472 Everolimus .75 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0480 Everolimus 2.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0481 Everolimus 5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0482 Everolimus 10 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0497 Everolimus 7.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0604 Everolimus 1 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0093-7766 Everolimus 2.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7767 Everolimus 5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7768 Everolimus 7.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7769 Everolimus 10 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0378-0005 Everolimus 2 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
  • 0378-0006 Everolimus 3 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 51991-821 QR Code

< Prev: 51991-820Next: 51991-822 >

Related Discussions:

Everolimus Face Rash
Side Effects of Everolimus including face and body rash; swollen feet...
Everolimus Side Effects
Everolimus Side Effects: Face and Body Rash...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.